Angion Biomedica Corp. Business Finance Contracts & Agreements

47 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Purchase Agreement between Elicio Therapeutics, Inc. and Purchasers (January 29, 2025)
Purchase Agreements
Angion Biomedica Corp.
Pharmaceuticals
NY
2025
Elicio Therapeutics, Inc. Form of Warrant to Purchase Common Stock (Exhibit 4.1)
Warrant Agreements
Angion Biomedica Corp.
Pharmaceuticals
NY
2025
Subsidiary Guarantee Agreement by Elicio Therapeutics, Inc. and Guarantors for Senior Secured Convertible Promissory Notes
Guaranty Agreements
Angion Biomedica Corp.
Pharmaceuticals
NY
2024
Intellectual Property Security Agreement between Elicio Therapeutics, Inc. and GKCC, LLC
Security Agreements
Angion Biomedica Corp.
Pharmaceuticals
NY
2024
Security Agreement between Elicio Therapeutics, Inc. and Investors dated August 12, 2024
Security Agreements
Angion Biomedica Corp.
Pharmaceuticals
2024
Securities Purchase Agreement between Elicio Therapeutics, Inc. and Purchasers (August 12, 2024)
Purchase Agreements
Angion Biomedica Corp.
Pharmaceuticals
NY
2024
Senior Secured Convertible Promissory Note between Elicio Therapeutics, Inc. and GKCC, LLC (Due February 15, 2026)
Note Agreements
Angion Biomedica Corp.
Pharmaceuticals
NY
2024
Elicio Therapeutics, Inc. Pre-Funded Warrant to Purchase Common Stock (2024)
Warrant Agreements
Angion Biomedica Corp.
Pharmaceuticals
NY
2024
Elicio Therapeutics, Inc. Warrant to Purchase Common Stock, Issued to [Holder], Dated [Issuance Date]
Warrant Agreements
Angion Biomedica Corp.
Pharmaceuticals
NY
2024
Elicio Therapeutics, Inc. Underwriting Agreement with JonesTrading Institutional Services LLC (June 28, 2024)
Underwriting Agreements
Angion Biomedica Corp.
Pharmaceuticals
NY
2024
Information Rights Agreement between Elicio Therapeutics, Inc. and Clal Biotechnology Industries Ltd. (May 30, 2023)
Investor Rights Agreements
Angion Biomedica Corp.
Pharmaceuticals
DE
2023
Note Purchase Agreement between Elicio Therapeutics, Inc. and Angion Biomedica Corp. dated January 17, 2023
Note Agreements
Angion Biomedica Corp.
Pharmaceuticals
DE
2023
Description of Angion Biomedica Corp. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Angion Biomedica Corp.
Pharmaceuticals
DE
2022
Description of Angion Biomedica Corp. Common Stock Registered Under Section 12 of the Exchange Act
Registration Rights Agreements
Angion Biomedica Corp.
Pharmaceuticals
DE
2021
Stock Purchase Agreement between Angion Biomedica Corp. and Vifor (International) Ltd. dated February 4, 2021
Stock Agreements
Angion Biomedica Corp.
Pharmaceuticals
DE
2021
Angion Biomedica Corp. 2021 Employee Stock Purchase Plan
Equity Distribution Agreements
Angion Biomedica Corp.
Pharmaceuticals
DE
2021
Underwriting Agreement between Angion Biomedica Corp. and Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated
Underwriting Agreements
Angion Biomedica Corp.
Pharmaceuticals
NY
2021
SBA Paycheck Protection Program Promissory Note between Angion Biomedica Corp. and Hanmi Bank
Note Agreements
Angion Biomedica Corp.
Pharmaceuticals
2021
Exercise of Stock Option Agreement – Angion Biomedica Corp.
Warrant Agreements
Angion Biomedica Corp.
Pharmaceuticals
2021
Angion Biomedica Corp. Non-Qualified Stock Option Certificate under 2015 Equity Incentive Plan
Warrant Agreements
Angion Biomedica Corp.
Pharmaceuticals
DE
2021
Angion Biomedica Corp. Incentive Stock Option Certificate under 2015 Equity Incentive Plan
Equity Distribution Agreements
Angion Biomedica Corp.
Pharmaceuticals
DE
2021
Angion Biomedica Corp. Second Amended and Restated 2015 Equity Incentive Plan (as Amended February 5, 2020)
Equity Distribution Agreements
Angion Biomedica Corp.
Pharmaceuticals
DE
2021
Amended and Restated Registration Rights Agreement between Angion Biomedica Corp. and Investors (March 31, 2020)
Registration Rights Agreements
Angion Biomedica Corp.
Pharmaceuticals
CA
2021
Broker Purchase Warrant Agreement between Angion Biomedica Corp. and Broker Holder (2018)
Warrant Agreements
Angion Biomedica Corp.
Pharmaceuticals
2021
Angion Biomedica Corp. Convertible Promissory Note Agreement
Note Agreements
Angion Biomedica Corp.
Pharmaceuticals
NY
2021
Common Stock Purchase Warrant Agreement between Angion Biomedica Corp. and Holder (2018)
Warrant Agreements
Angion Biomedica Corp.
Pharmaceuticals
2021
Lock-Up Agreement between Aegis Capital Corp. and Angion Biomedica Corp. Shareholder (2014)
Underwriting Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
Representative’s Warrant Agreement between Angion Biomedica Corp. and Aegis Capital Corp.
Warrant Agreements
Angion Biomedica Corp.
Pharmaceuticals
NY
2014
Underwriting Agreement between Angion Biomedica Corp. and Aegis Capital Corp.
Underwriting Agreements
Angion Biomedica Corp.
Pharmaceuticals
NY
2014
NSF SBIR Phase I Grant Award Agreement between National Science Foundation and Angion Biomedica Corp.
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice to Angion Biomedica Corporation for Aldosterone Synthase Inhibitor Research
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice to Angion Biomedica Corp for Liver Fibrosis Therapeutic Project
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH SBIR Grant Award Notice to Angion Biomedica Corp. for Antifibrotic Therapy Research
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice to Angion Biomedica Corp. for Anti-Fibrotic Therapy Research (SBIR Program)
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice for Angion Biomedica Corp. (SBIR Program, Project R43HL114298)
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice to Angion Biomedica Corporation for Alcoholic Liver Disease Research
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice to Angion Biomedica Corporation for Clinical Study on DGF Using Paired Kidneys
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice to Angion Biomedica Corporation for Renal Transplantation Clinical Study
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
Amended and Restated Unsecured Promissory Note between Itzhak D. Goldberg and Angion Biomedica Corp.
Note Agreements
Angion Biomedica Corp.
Pharmaceuticals
NJ
2014
Agreement Regarding Novapark Membership Interests, Guaranty, and Note Settlement among Dr. Goldberg, Angion Biomedica Corp., and Novapark, LLC
Modification Agreements
Angion Biomedica Corp.
Pharmaceuticals
NY
2014